NJ Advance Media learned that this highly contagious variant of the coronavirus has been first discovered in the United Kingdom in New Jersey and then in multiple states in the United States.
Governor Phil Murphy and the state’s top health official will announce at a COVID-19 briefing in Trenton on Friday that Garden State has confirmed two cases.
Scientists say that this mutation is more infectious. But there is no evidence that it is more lethal or resistant to vaccines. New Jersey has joined at least 20 states that have confirmed the strain.
“We report that two confirmed cases of COVID-1
Health Commissioner Judy Persichilli (Judy Persichilli) will announce that the first confirmed case is from a man in his 60s in Ocean County, and the other is a child traveling to northern New Jersey.
“(The man) has no travel experience and no clear contact with other sick people,” Persichilli will say. “This child was examined in New York City on January 11 and has no symptoms. The local health department is further investigating the case.”
The man developed symptoms in late December and was tested by PCR on January 6. He has never been hospitalized and has since recovered.
The governor stated as early as late December that the new strain is likely to be used in the state.
Murphy said in a December 28 briefing: “We are assuming this pressure has arrived.”
It was discovered in neighboring New York in early January.
Coronavirus resources: Real-time map tracker | communication | Homepage
Viruses usually only through normal evolution can obtain small changes in one or two letters in their genetic letters. Slightly modified strains may become the most common strains in a country or region, simply because the strain first gained a place in the region or market, or because the “super spreader” incident helped it take root.
The bigger concern is that when the virus mutates by changing the protein on its surface to help it escape drugs or the immune system, it will create greater concern.
But New Jersey health officials have stated that they believe this variant will not limit the effectiveness of this virus vaccine.
Ed Lifshitz, medical director of the Infectious Disease Service of the Ministry of Health, said at the end of last month: “This vaccine is likely to continue to work.”
He said: “The reason for this is that the virus will mutate enough that the antibodies in the vaccine can’t stop it,” he also said, “it may also mutate enough to not catch it well. Cells in cells. Number one.”
He added: “I know that cell vaccine manufacturers are studying this. Of course, we have always wanted to attract attention because we never said that the virus will never be involved, but I hope this vaccine will be equally or almost effective It’s as effective as the new version.”
The Associated Press contributed to this report.
Our news needs your support.Please subscribe today NJ.com
Matt Arco may be at firstname.lastname@example.org.